Form 4/A for AGX ARGAN INC
Accepted 2025-08-29 00:00:00 ET · period of report 2025-07-29 · accession 0001415889-25-023298 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMA | 2025-08-29 | 2025-07-29+ | AGX | Collins Charles Edwin IV | CEO, GEMMA | M - OptEx | $45.22 | +6,500 | 26.0K | +33% | +$293.9K |
| DMA | 2025-08-29 | 2025-07-29+ | AGX | Collins Charles Edwin IV | CEO, GEMMA | S - Sale+OE | $244.19 | -6,500 | 21.0K | -24% | -$1.59M |
| DMA | 2025-08-29 | 2025-07-29+ | AGX | Collins Charles Edwin IV | CEO, GEMMA | M - OptEx | $45.22 | -6,500 | 57.2K | -10% | -$293.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-29 | M | A | 1,500 | $46.35 | 22,506 | D | — | — | (F1) On July 29, 2025 the Reporting Person exercised a portion of his stock option awarded on January 11, 2018 to purchase 1,500 shares of the Issuer's common stock at price of $46.35 per share. |
| 2 | Common | Common Stock | 2025-07-31 | S | D | 5,000 | $245.00 | 21,006 | D | — | — | (F5) On July 31, 2025, the Reporting Person sold 5,000 shares of the Issuer's common stock on the open market at an average price of $245 per share. |
| 3 | Common | Common Stock | 2025-07-31 | M | A | 2,735 | $46.35 | 23,741 | D | — | — | (F3) On July 31, 2025, the Reporting Person exercised the remainder of his stock option awarded on January 11, 2018 to purchase 2,735 shares of the Issuer's common stock at a price of $46.35 per share. |
| 4 | Common | Common Stock | 2025-07-31 | M | A | 2,265 | $43.10 | 26,006 | D | — | — | (F4) On July 31, 2025, the Reporting Person exercised a portion of his stock option awarded on September 12, 2018 to purchase 2,265 shares of the Issuer's common stock at a price of $43.10 per share. |
| 5 | Common | Common Stock | 2025-07-29 | S | D | 1,500 | $241.50 | 21,006 | D | — | — | (F2) On July 29, 2025 the Reporting Person sold 1,500 shares of common stock on the open market at an average price of $241.50 per share. |
| 6 | Derivative | Option to Purchase Common Stock | 2025-07-31 | M | D | 2,265 | $43.10 | 52,235 | D | $43.10 · 2019-09-12 to 2028-09-12 | 2,265 Common Stock | (F4) On July 31, 2025, the Reporting Person exercised a portion of his stock option awarded on September 12, 2018 to purchase 2,265 shares of the Issuer's common stock at a price of $43.10 per share. |
| 7 | Derivative | Option to Purchase Common Stock | 2025-07-31 | M | D | 2,735 | $46.35 | 54,500 | D | $46.35 · 2019-01-11 to 2028-01-11 | 2,735 Common Stock | (F3) On July 31, 2025, the Reporting Person exercised the remainder of his stock option awarded on January 11, 2018 to purchase 2,735 shares of the Issuer's common stock at a price of $46.35 per share. |
| 8 | Derivative | Option to Purchase Common Stock | 2025-07-29 | M | D | 1,500 | $46.35 | 57,235 | D | $46.35 · 2019-01-11 to 2028-01-11 | 1,500 Common Stock | (F1) On July 29, 2025 the Reporting Person exercised a portion of his stock option awarded on January 11, 2018 to purchase 1,500 shares of the Issuer's common stock at price of $46.35 per share. |